Hydroxychloroquine has been studied as a potential adjunctive therapy in the treatment of chronic kidney disease (CKD) associated with autoimmune conditions such as lupus nephritis. <a href="
https://hydroquin.com">plaquenil buy</a> Its anti-inflammatory and immunomodulatory effects may help to reduce proteinuria, preserve renal function, and improve long-term outcomes in patients with CKD. However, the evidence supporting its use in this context is limited, and further research is needed to establish its efficacy and safety in patients with CKD.